4\'-Brom-2\'-hydroxypropiophenon
Lieferant:
Sigma-Aldrich
Beschreibung:
1-Nonen, Sigma-Aldrich®
Artikel-Nr:
(34196-10MG)
Lieferant:
Sigma-Aldrich
Hersteller-Artikelnummer::
34196-10MG
Lokale Artikelnummer::
SUPL34196-10MG
Beschreibung:
Dimetridazol-[1-Methyl-D3], Supelco®
VE:
1 * 10 mg
Artikel-Nr:
(HEWL8003-0573)
Lieferant:
Agilent
Hersteller-Artikelnummer::
8003-0573
Lokale Artikelnummer::
HEWL8003-0573
Beschreibung:
These sample and skimmer cones are equivalent to those from PerkinElmer ICP-MS for complete confidence.
VE:
1 * 1 ST
Lieferant:
COMBI-BLOCKS
Beschreibung:
3-Phenylanilin Hydrochlorid
Artikel-Nr:
(BLDPBD01215945-250)
Lieferant:
BLD PHARMATECH GMBH
Hersteller-Artikelnummer::
BD01215945-250
Lokale Artikelnummer::
BLDPBD01215945-250
Beschreibung:
5-((3AS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)-5H-dibenzo[b,f]azepine 98%
VE:
1 * 250 mg
Lieferant:
Sigma-Aldrich
Beschreibung:
N-Methyl-N-(trimethylsilyl)trifluoracetamid, Supelco®
Artikel-Nr:
(USBE3234)
Lieferant:
USBECK Laborgeräte
Hersteller-Artikelnummer::
3234
Lokale Artikelnummer::
USBE3234
Beschreibung:
Flexible double spatulas made of stainless steel.
VE:
1 * 1 ST
Artikel-Nr:
(424237L)
Lieferant:
VWR Chemicals
Lokale Artikelnummer::
VWRC424237L
Beschreibung:
β-Nicotinamid-Adenin-Dinucleotid Dinatriumsalz, reduzierte Form (NADH-Na<sub>2</sub>)
VE:
1 * 0,5 g
Artikel-Nr:
(SPCMT2016-1KG)
Lieferant:
Spectrum Chemical
Hersteller-Artikelnummer::
T2016-1KG
Lokale Artikelnummer::
SPCMT2016-1KG
Beschreibung:
N,N,N',N'-Tetrakis(2-hydroxypropyl)ethylenediamine ≥98%
VE:
1 * 1 kg
Artikel-Nr:
(216-1210)
Lieferant:
MORGAN ADVANCED MATERIALS HALD
Hersteller-Artikelnummer::
L888/00
Lokale Artikelnummer::
HALDL888/00
Beschreibung:
Porzellan, glasiert.
VE:
1 * 1 ST
Artikel-Nr:
(BOSSBS-1361R-A555)
Lieferant:
Bioss
Hersteller-Artikelnummer::
BS-1361R-A555
Lokale Artikelnummer::
BOSSBS-1361R-A555
Beschreibung:
Multifunctional transcription factor in ER stress response. Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress. Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes. Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes. Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF1B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L. Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG). Inhibits the canonical Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-binding properties and repressing its transcriptional activity. Plays a regulatory role in the inflammatory response through the induction of caspase-11 (CASP4/CASP11) which induces the activation of caspase-1 (CASP1) and both these caspases increase the activation of pro-IL1B to mature IL1B which is involved in the inflammatory response.
VE:
1 * 100 µl
Artikel-Nr:
(BOSSBS-11800R-A555)
Lieferant:
Bioss
Hersteller-Artikelnummer::
BS-11800R-A555
Lokale Artikelnummer::
BOSSBS-11800R-A555
Beschreibung:
Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
VE:
1 * 100 µl
Artikel-Nr:
(BOSSBS-11800R-A488)
Lieferant:
Bioss
Hersteller-Artikelnummer::
BS-11800R-A488
Lokale Artikelnummer::
BOSSBS-11800R-A488
Beschreibung:
Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
VE:
1 * 100 µl
Artikel-Nr:
(BOSSBS-11800R-CY5)
Lieferant:
Bioss
Hersteller-Artikelnummer::
BS-11800R-CY5
Lokale Artikelnummer::
BOSSBS-11800R-CY5
Beschreibung:
Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
VE:
1 * 100 µl
Artikel-Nr:
(BOSSBS-1361R-HRP)
Lieferant:
Bioss
Hersteller-Artikelnummer::
BS-1361R-HRP
Lokale Artikelnummer::
BOSSBS-1361R-HRP
Beschreibung:
Multifunctional transcription factor in ER stress response. Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress. Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes. Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes. Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF1B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L. Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG). Inhibits the canonical Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-binding properties and repressing its transcriptional activity. Plays a regulatory role in the inflammatory response through the induction of caspase-11 (CASP4/CASP11) which induces the activation of caspase-1 (CASP1) and both these caspases increase the activation of pro-IL1B to mature IL1B which is involved in the inflammatory response.
VE:
1 * 100 µl
Artikel-Nr:
(BOSSBS-1361R-A647)
Lieferant:
Bioss
Hersteller-Artikelnummer::
BS-1361R-A647
Lokale Artikelnummer::
BOSSBS-1361R-A647
Beschreibung:
Multifunctional transcription factor in ER stress response. Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress. Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes. Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes. Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF1B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L. Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG). Inhibits the canonical Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-binding properties and repressing its transcriptional activity. Plays a regulatory role in the inflammatory response through the induction of caspase-11 (CASP4/CASP11) which induces the activation of caspase-1 (CASP1) and both these caspases increase the activation of pro-IL1B to mature IL1B which is involved in the inflammatory response.
VE:
1 * 100 µl
Preis auf Anfrage
Lager für diesen Artikel ist begrenzt, kann aber in einem Lagerhaus in Ihrer Nähe zur Verfügung. Bitte stellen Sie sicher, dass Sie in sind angemeldet auf dieser Seite, so dass verfügbare Bestand angezeigt werden können. Wenn das
![]()
Lager für diesen Artikel ist begrenzt, kann aber in einem Lagerhaus in Ihrer Nähe zur Verfügung. Bitte stellen Sie sicher, dass Sie in sind angemeldet auf dieser Seite, so dass verfügbare Bestand angezeigt werden können. Wenn das
![]()
Dieses Produkt kann nur an eine Lieferadresse versandt werden die über die entsprechende Lizenzen verfügt. Für weitere Hilfe bitte kontaktieren Sie Ihr VWR Vertriebszentrum.
-Additional Documentation May be needed to purchase this item. A VWR representative will contact you if needed.
Dieses Produkt wurde von Ihrer Organisation gesperrt. Bitte kontaktieren Sie Ihren Einkauf für weitere Informationen.
Dieses Produkt ist Ersatz für den von Ihnen gewünschten Artikel.
Dieses Produkt ist nicht mehr verfügbar. Bitte kontaktieren Sie den VWR Kundenservice.
|
|||||||||